R Adams Cowley Shock Trauma Center is a free-standing trauma hospital in Baltimore, Maryland and is part of the University of Maryland Medical Center. It was the first facility in the world to treat shock. Shock Trauma was founded by R Adams Cowley, considered the father and major innovator of trauma medicine.

During the past decade, University of Maryland, R Adams Cowley Shock Trauma Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 12 clinical trials were completed, i.e. on average, 41.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Maryland, R Adams Cowley Shock Trauma Center" #1 sponsor was "Major Extremity Trauma Research Consortium" with 18 trials, followed by "University of Maryland, Baltimore" with 12 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials sponsored, "BrainScope Company, Inc." with 2 trials sponsored and "AO Clinical Investigation and Publishing Documentation" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Maryland, R Adams Cowley Shock Trauma Center" #1 collaborator was "United States Department of Defense" with 8 trials as a collaborator, "McMaster University" with 3 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Dartmouth College" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Maryland, R Adams Cowley Shock Trauma Center" are "Traumatic Brain Injury" (4 trials), "Post Operative Surgical Site Infection" (3 trials), "Respiratory Distress Syndrome, Adult" (3 trials), "Trauma" (3 trials) and "Brain Injuries" (2 trials). Many other conditions were trialed in "University of Maryland, R Adams Cowley Shock Trauma Center" in a lesser frequency.

Most popular intervention types in "University of Maryland, R Adams Cowley Shock Trauma Center" are "Drug" (15 trials), "Other" (10 trials), "Procedure" (9 trials), "Device" (6 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "BrainScope Ahead 200" (2 trials), "Full Feeding" (2 trials), "Minimal (Trophic) Feeding" (2 trials) and "10% povidone-iodine (1% free iodine) in purified water" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland, R Adams Cowley Shock Trauma Center" are 48 trials for "All" genders.

Currently, there are 14 active trials in "University of Maryland, R Adams Cowley Shock Trauma Center". 3 are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 29 completed trials in University of Maryland, R Adams Cowley Shock Trauma Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland, R Adams Cowley Shock Trauma Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".

University of Maryland, R Adams Cowley Shock Trauma Center has several departments that took part in Clinical trials: "Maryland Center for MS" - 9 trials, "University of Maryland Medical Center; Department of Neurology" - 5 trials, "University of Maryland, Baltimore & Baltimore VA Medical Center" - 4 trials, "University of Maryland Medical System Investigational Pharmacy" - 2 trials, "University of Maryland Eye Associates" - 2 trials